Work

Supplementary Materials for "Safety of Teplizumab in Stages 2 and 3 Type 1 Diabetes: A Systematic Review and Meta-Analysis of Adverse Events"

Year: 2026

Type: supplementary-materials

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.21946706

Authors: Frankowski Dagostin, Andressa, Sa, Renata, Araujo Silva Dias, Lorena, Potiguara de Sousa, Ana Luiza, Holland, Soemiwati

Institutions: Vita-Salute San Raffaele University, Universidade Federal do Rio de Janeiro, Universidade Católica de Brasília, Hackensack Meridian School of Medicine

Language: English

Topic: Diabetes and associated disorders

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7203559631

Cites:

Cited by:

Related to: 8